An astonishing 82% of drug shortages are listed as reason unknown. The other causes include manufacturing, discontinuation, raw materials, and…
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and…
CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More